European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025
Long-Term Outcomes Following Off-pump Coronary Artery Bypass Grafting Using Only 3 In situ Arterial Grafts.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Niinami Hiroshi, Endo Yuki, Morita Kozo, Hattori Masashi, Domoto Satoru, Ichihara Yuki, Saito Satoshi, Hamasaki Azumi, Yoshitake Akihiro
Аннотация
OBJECTIVES: Coronary artery bypass grafting (CABG) using bilateral internal thoracic artery (BITA) conduits can achieve good outcomes for multivessel lesions. This study evaluated early angiographic patency and outcomes following off-pump CABG (OPCAB) using only in situ BITA and right gastroepiploic artery (rGEA) grafts.
METHODS: This retrospective analysis included patients undergoing OPCAB using only in situ skeletonized BITA and rGEA grafts (July 2007 to March 2019). The primary outcome was all-cause mortality. Secondary outcomes were early graft patency and major adverse cardiac and cerebral events (MACCE).
RESULTS: During the study period, OPCAB using only in situ skeletonized BITA/rGEA grafts was performed in 302 of 1034 patients with triple-vessel disease (29.2%). The number of reconstructed branches was 4 [3-4] per patient. Median follow-up duration was 9.3 [6.6-11.8] years. No deaths occurred during the 30-day postoperative period, whereas 43 deaths (14.3%), including 11 cardiovascular-related deaths (3.6%), occurred during long-term follow-up. MACCE occurred in only 1 patient during the 30-day postoperative period and in 62 patients (20.2%) during long-term follow-up. Early graft patency rate after surgery was 98.9%. Estimated overall survival rates at 5, 10, and 12 years of follow-up were 92.6%, 85.7%, and 77.7%, respectively. Corresponding values for MACCE-free survival were 89.6%, 79.9%, and 69.2%. Diabetes mellitus was not significantly associated with all-cause mortality or MACCE.
CONCLUSIONS: OPCAB using only in situ skeletonized BITA and rGEA grafts achieved excellent early angiographic patency and long-term outcomes, suggesting that applying our criteria for rGEA use might help improve the long-term outcomes of CABG.
METHODS: This retrospective analysis included patients undergoing OPCAB using only in situ skeletonized BITA and rGEA grafts (July 2007 to March 2019). The primary outcome was all-cause mortality. Secondary outcomes were early graft patency and major adverse cardiac and cerebral events (MACCE).
RESULTS: During the study period, OPCAB using only in situ skeletonized BITA/rGEA grafts was performed in 302 of 1034 patients with triple-vessel disease (29.2%). The number of reconstructed branches was 4 [3-4] per patient. Median follow-up duration was 9.3 [6.6-11.8] years. No deaths occurred during the 30-day postoperative period, whereas 43 deaths (14.3%), including 11 cardiovascular-related deaths (3.6%), occurred during long-term follow-up. MACCE occurred in only 1 patient during the 30-day postoperative period and in 62 patients (20.2%) during long-term follow-up. Early graft patency rate after surgery was 98.9%. Estimated overall survival rates at 5, 10, and 12 years of follow-up were 92.6%, 85.7%, and 77.7%, respectively. Corresponding values for MACCE-free survival were 89.6%, 79.9%, and 69.2%. Diabetes mellitus was not significantly associated with all-cause mortality or MACCE.
CONCLUSIONS: OPCAB using only in situ skeletonized BITA and rGEA grafts achieved excellent early angiographic patency and long-term outcomes, suggesting that applying our criteria for rGEA use might help improve the long-term outcomes of CABG.